Unlearn AI logo

Unlearn AI

Paid

Enhance clinical trials and patient outcomes with Unlearn AI. Discover how this innovative platform uses digital twins for smarter, faster drug

1
#youtube#twitter
Inputs: textOutputs: text
Type
Saas
Company
Unlearn

About Unlearn AI

Unlearn uses AI to create digital twins of clinical trial participants, streamlining clinical development and enabling confident decision-making. Their platform simulates outcomes for every participant at the beginning of a clinical study, predicting every clinical outcome at every future time point with precision. They generate digital twins of patients in studies, delivered through a state-of-the-art, easy-to-use platform that minimizes trial failure, cuts costs, and accelerates timelines.

How to Use

Unlearn's platform allows users to design and run smaller clinical trials, explore predicted outcomes for subgroups of participants, and simulate protocol scenarios in early stages of trial design. Users can book a demo to learn how Unlearn can support their study.

Key Features

  • Digital twin generation for clinical trial participants
  • Outcome prediction with high precision
  • Trial design simulation
  • Real-time insights and data-driven decision-making

Use Cases

  • Accelerating trial timelines by designing smaller, more powerful studies
  • Enhancing decision-making by exploring predicted outcomes for participant subgroups
  • De-risking trial design by simulating protocol scenarios

Key Features

Digital twin generation for clinical trial participants
Outcome prediction with high precision
Trial design simulation
Real-time insights and data-driven decision-making

Pros & Cons

Pros
  • Advanced digital twin methodology claimed to be qualified by EMA and aligned with FDA guidance
  • Integrated platform that connects trial planning, monitoring, and analysis in one workspace
  • Reported real-world benefits including 33% control arm size reduction and 4 months enrollment time savings (approximate values)
  • Supports a wide range of therapeutic areas beyond neuroscience
  • Enables reproducible and evidence-linked trial design simulations
Cons
  • Platform is specialized for clinical research and may not be applicable outside drug development
  • Effectiveness depends on the quality and availability of historical clinical trial and real-world data
  • Pricing details are not publicly listed on the homepage; likely enterprise-level and should be verified
  • May require integration with existing clinical data management systems and institutional workflows
  • Digital twin methodology may have a learning curve for trial teams new to AI-based approaches

Best For

Accelerating trial timelines by designing smaller, more powerful studiesEnhancing decision-making by exploring predicted outcomes for participant subgroupsDe-risking trial design by simulating protocol scenarios

Alternatives to Unlearn AI

FAQ

What are digital twins in the context of clinical trials?
Digital twins are AI-generated forecasts of clinical trial participants' expected outcomes if they had received control treatment. They are used as external comparators to reduce variability and improve detection of treatment effects.
Is the digital twin methodology approved by regulatory agencies?
The platform states that its digital twin methodology is qualified by the European Medicines Agency (EMA) and aligned with current FDA guidance. Users should verify the latest regulatory status for their specific trial design.
What types of clinical trials can Unlearn AI support?
Based on available information, the platform supports early-stage, open-label, and randomized controlled trials across multiple therapeutic areas including neuroscience, immunology, and metabolic disease.
How does the trial planning module work?
The planning module includes Scout (literature search), Hindsight (data exploration), and SimLab (scenario simulation). These tools allow teams to search regulatory precedents, validate assumptions against historical data, and compare trial design options.
Is there a free tier available?
The platform appears to be offered under a paid pricing model. Any free trial or demo should be confirmed directly with Unlearn AI.
What data sources are integrated for literature and regulatory searches?
According to the website, Scout searches PubMed, ClinicalTrials.gov, and drugs@FDA, providing a centralized repository of relevant documents.